Your browser doesn't support javascript.
loading
Effect of citric-acid dialysate on the QTC-interval.
Ter Meulen, Karlien J; Hermans, Ben J M; van der Sande, Frank M; Canaud, Bernard; Konings, Constantijn J A M; Kooman, Jeroen P; Delhaas, Tammo.
Afiliación
  • Ter Meulen KJ; Division of Nephrology, Department of Internal Medicine, Maastricht University Medical Center, PO Box 5800, 6202AZ, Maastricht, The Netherlands. karlien.ter.meulen@mumc.nl.
  • Hermans BJM; Division of Nephrology, Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands. karlien.ter.meulen@mumc.nl.
  • van der Sande FM; Department of Biomedical Engineering, Maastricht University, Maastricht, The Netherlands.
  • Canaud B; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Konings CJAM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
  • Kooman JP; Division of Nephrology, Department of Internal Medicine, Maastricht University Medical Center, PO Box 5800, 6202AZ, Maastricht, The Netherlands.
  • Delhaas T; Fresenius Medical Care, Bad Homburg, Germany.
Sci Rep ; 11(1): 9909, 2021 05 10.
Article en En | MEDLINE | ID: mdl-33972581
Lower dialysate calcium (dCa) concentration and dialysate citric-acidification may positively affect calcification propensity in serum of haemodialysis (HD) patients. However, the accompanying lower ionized blood calcium concentration may lead to a prolonged cardiac action potential, which is possibly pro-arrhythmic. The aim of this study is to investigate the influence of citric-acid dialysate on the QT-interval corrected for heart rate (QTc) compared to conventional dialysate with different dCa concentrations. We conducted a four-week multicentre, randomized cross-over trial. In week one and three patients received acetic-acid dialysate with a dCa of 1.50 mmol/l (A1.5), in week two and four acetic-acid dialysate with a dCa of 1.25 mmol/l (A1.25) or citric-acid dialysate (1.0 mmol/l) with a dCa of 1.50 mmol/l (C1.5) depending on randomization. Patients had continuous ECG monitoring during one session in week one, two and four. The data of 13 patients were available for analysis. Results showed a significant though limited increase of QTc with C1.5 (from 427 to 444 ms (start to end); p = 0.007) and with A1.25 (from 431 to 449 ms; p < 0.001), but not with A1.5 (from 439 to 443 ms; p = 0.13). In conclusion, we found that the use of C1.5 or A1.25 is associated with a significant prolongation of QTc which was however relatively limited.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
...